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Apical radial glia (aRGs) are predominant progenitors
during corticogenesis. Perturbing their function
leads to corticalmalformations, including subcortical
heterotopia (SH), characterized by the presence of
neurons below the cortex. EML1/Eml1 mutations
lead to SH in patients, as well as to heterotopic cor-
tex (HeCo) mutant mice. In HeCo mice, some aRGs
are abnormally positioned away from the ventricular
zone (VZ). Thus, unraveling EML1/Eml1 function will
clarify mechanisms maintaining aRGs in the VZ. We
pinpoint an unknown EML1/Eml1 function in primary
cilium formation. InHeCo aRGs, cilia are shorter, less
numerous, and often found aberrantly orientedwithin
vesicles. Patient fibroblasts and human cortical
progenitors show similar defects. EML1 interacts
with RPGRIP1L, a ciliary protein, and RPGRIP1L
mutations were revealed in a heterotopia patient.
We also identify Golgi apparatus abnormalities in
EML1/Eml1 mutant cells, potentially upstream of
the cilia phenotype. We thus reveal primary cilia
mechanisms impacting aRG dynamics in physiolog-
ical and pathological conditions.
INTRODUCTION
The cerebral cortex is a highly organized structure whose devel-
opment depends on different progenitor cell types. These give
rise to post-mitotic neurons that migrate across the developing
cortical wall to their final positions in the cortical plate. Apical1596 Cell Reports 28, 1596–1611, August 6, 2019 ª 2019 The Author
This is an open access article under the CC BY-NC-ND license (http://radial glia (aRGs) are the main progenitor type in early cortico-
genesis and are responsible for the production of other progen-
itors, hence regulating the final neuronal output (Uzquiano et al.,
2018). aRGs are localized in the proliferative ventricular zone (VZ)
and have a characteristic morphology, including a basal process
extending to the pial surface and an apical process descending
to the ventricular surface. The apical process of aRGs terminates
by an endfoot characterized by the presence of a centrosome
that during interphase acts as a basal body docking a primary
cilium. These two structures are crucial for aRG polarity and
function, and abnormal behavior of aRGs disrupts neocortical
development, causing severe cortical malformations (Bizzotto
and Francis, 2015). Primary cilium anomalies, as well as defects
in pathways dependent on this organelle, are expected to
severely impact neural progenitor behavior as well as other steps
of corticogenesis (Ding et al., 2019; Foerster et al., 2017; Gabriel
et al., 2016; Wang et al., 2016; Guo et al., 2015; Higginbotham
et al., 2013; Li et al., 2011; Wilson et al., 2012).
We and others identified pathogenic mutations in EML1 in a
specific group of cortical malformations characterized by atyp-
ical subcortical heterotopia (SH), corpus callosum agenesis,
and macrocrania (Kielar et al., 2014; Shaheen et al., 2017).
EML1 codes for a microtubule-associated protein. Remarkably,
a retrotransposon insertion disrupting the mouse ortholog
Eml1 leads to a similar phenotype in the heterotopic cortex
(HeCo) mouse mutant (Croquelois et al., 2009; Kielar et al.,
2014). The latter represents a unique model to decipher the bio-
logical basis of SH.
HeCo mice show progenitor anomalies from the early stages
of corticogenesis thought to be responsible for the heterotopia
phenotype (Bizzotto et al., 2017; Kielar et al., 2014). Some
aRGs leave the VZ and divide in aberrant basal positions (Kielar
et al., 2014). However, the pathological mechanisms leading tos.
creativecommons.org/licenses/by-nc-nd/4.0/).
the detachment of these cells in the HeCo VZ remain vastly
unexplored.
The primary cilium is a microtubule-based antenna-like
structure that serves as platform for signaling pathways.
In aRG apical endfeet, this organelle protrudes within the
ventricle in order to sense signals from the cerebrospinal
fluid. It is formed after mitosis, when the centrosome, composed
of two centrioles at the spindle pole, is trafficked toward the
apical surface. During this journey, the centrosome associates
with de novo synthesized membrane or ciliary remnants, which
are often carried in vesicle-like structures and will then become
the basal body-primary cilium complex (Bernabe´-Rubio and
Alonso, 2017; Paridaen et al., 2013). Once this complex
reaches the plasma membrane, the basal body is docked and
the primary cilium is inserted in the apical membrane. Trafficking
of proteins from the Golgi apparatus is essential for the assembly
of the basal body-primary cilium complex (Bernabe´-Rubio and
Alonso, 2017; Madhivanan and Aguilar, 2014). Therefore, correct
formation of primary cilia depends on diverse subcellular pro-
cesses that when disrupted could be responsible for the appear-
ance of cilia-related pathologies (Madhivanan and Aguilar,
2014).
Here, we reveal a severe disruption of primary cilia in Eml1/
EML1 mutant conditions, not only in HeCo aRGs but also in
patient fibroblasts and human induced pluripotent stem cell
(iPSC)-derived cortical progenitors. Thus, Eml1/EML1 has an
unexpected role in primary cilia formation. We also uncover
a ciliary protein partner of EML1, RPGRIP1L, and report the
first heterotopia patient showing mutations in this protein.
Searching for upstream mechanisms potentially responsible
for perturbed primary cilia, converging data pointed toward
abnormal Golgi apparatus function in Eml1/EML1 mutant con-
ditions. We show here signs of abnormal Golgi structure and/
or function in HeCo aRGs as well as patient fibroblasts and
iPSC-derived cortical progenitors. We hence reveal perturbed
Golgi apparatus mechanisms likely to be involved in primary
cilium formation that most probably contribute to the aRG
delamination phenotype.
RESULTS
Perturbation in Early Stages of Corticogenesis
Alterations in the number and distribution of g-tubulin+ and
Arl13b+ puncta, identifying centrosomes and primary cilia,
respectively, were recently observed in the embryonic day
13.5 (E13.5) HeCo VZ (Bizzotto et al., 2017). For a view of the
ventricular surface only, en face imaging was performed in
combination with these two markers in wild-type (WT) and
HeCo brains at the same developmental time point, together
with immunostaining for F-actin, in order to delineate apical
domains (Figure 1A). Using this approach, we confirmed a
decrease of g-tubulin+ and Arl13b+ puncta at the HeCo ventric-
ular surface (Figures 1B and 1C). We further analyzed the total
number of apical domains and quantified centrosome and
primary-cilium-containing endfeet in WT and HeComice. All api-
cal domains as well as centrosome-containing apical endfeet
(with or without primary cilia) were decreased in the HeCo ven-
tricular surface (Figures 1D–1F), in fitting with aRG delaminationat E13.5 (Kielar et al., 2014). Apical domains not containing
centrosome and primary cilia did not differ between HeCo and
WT mice (Figure 1G).
Given that Eml1 is expressed in the mouse VZ as early as
E12.5 (Bizzotto et al., 2017), WT and HeCo cortices were also
compared at this time point. First, a 30-min bromodeoxyuridine
(BrdU) pulse was performed to analyze the position of cycling
progenitor cells in the E12.5 cortical wall. Immunohistochemistry
for BrdU and Ki67 confirmed the presence of a proportion of
aberrant, superficially localized BrdU+Ki67+ progenitor cells as
previously observed at E13.5 (Figures S1A and S1B; Kielar
et al., 2014). At E12.5, en face imaging showed no significant
change in the number of g-tubulin+ and Arl13b+ puncta at the
HeCo ventricular surface compared to WT, although tendencies
for a decrease were observed, possibly indicating an incipient
phenotype (Figures S1C–S1E). Apical domain and endfeet
numbers were also analyzed, revealing tendencies similar to
the E13.5 data (Figures S1F–S1I). A significant decrease in the
number of centrosome and primary cilia containing apical end-
feet per region of interest (ROI) was observed at E12.5 (Fig-
ure S1G). There was a slight but significant increase in the
number of apical domains without centrosome and primary cilia
at the HeCo ventricular surface (Figure 1I).
Analyses of the numbers of aRG endfeet at E12.5 and E13.5
support the hypothesis that some Eml1mutant aRGs delaminate
from the ventricular surface at the early stages of corticogenesis.
Primary Cilia Formation Is Impaired in Eml1 Mutant
Conditions
We next questioned if, as well as reduced Arl13b puncta, pri-
mary cilia structure was abnormal in HeCo aRGs. Primary cilia
length was first measured from en face Arl13b immunodetec-
tion, a parameter often studied to investigate defects in their
assembly and/or disassembly (Kheradmand Kia et al., 2012).
In addition to their decrease in number, primary cilia were
found to be shorter at the HeCo ventricular surface at both
E12.5 and E13.5 (Figures 1H, 1I, S1J, and S1K). Since the
HeCo ventricular surface seemed more severely affected at
E13.5, we focused on this stage to further understand the
mechanisms involved.
In order to further examine the HeCo primary cilium pheno-
type, we analyzed their ultrastructure and subcellular localization
in WT and HeCo brains at E13.5 by electron microscopy
(EM) (Figure 2A). In WT aRG endfeet, centrioles are observed
in close vicinity to the apical plasma membrane, the mother
centriole acting as basal body and thus docking a primary cilium
protruding in the ventricle (Figure 2A). In agreement with the en
face imaging findings, aRG primary cilia measured from EM
data were found to be shorter in HeCo compared to WT (Figures
2A–2C). In addition, when short cilia could be observed, these
structures often lacked a properly formed basal body. Instead,
densely packedmicrotubules were often present in place of cen-
trioles (Figure 2A, white arrow). Furthermore, a significant in-
crease in the number of cilia within vesicle-like structures was
also evident in HeCo aRGs compared to WT (Figure 2A, black
asterisk, and Figure 2D). These were often also mis-oriented
basally rather than facing the ventricle (Figure 2A, white asterisk,
and Figure 2E).Cell Reports 28, 1596–1611, August 6, 2019 1597
Figure 1. Centrosomes, Primary Cilia, and Apical Endfeet Are Decreased at the HeCo Ventricular Surface
(A) En face confocal imaging of the WT and HeCo ventricular surface using F-actin (white), anti-g-tubulin (green), and anti-Arl13b (red) immunostaining.
(B) Quantification of g-tubulin+ puncta per ROI in WT and HeCo mice.
(C) Quantification of Arl13b+ puncta per ROI in WT and HeCo mice.
(D) Quantification of number of apical domains in WT and HeCo mice.
(E) Quantification of centrosome and primary cilium-containing apical endfeet in WT and HeCo mice.
(F) Quantification of centrosome-containing apical endfeet without primary cilium in WT and HeCo mice.
(G) Quantification of apical domains without centrosome and primary cilium in WT and HeCo mice. This represents 17% and 20% of the total number of apical
domains, respectively.
(H and I) Quantification of Arl13b+ primary cilia length in WT (n = 5 from 3 litters, 110 primary cilia) and HeCo (n = 5 from 4 litters, 61 primary cilia). Each point
represents an embryo (H) or primary cilium (I).
Each point in (B)–(G) represents an embryo (WT: n = 7 from 4 litters; HeCo: n = 6 from 5 litters). Scale bar, 10 mm (A). Data are represented as mean ± SEM and
unpaired t test (B–G), and box and whisker plots show the median ± minimum-maximum range followed by Mann-Whitney test (H and I). ****p < 0.0001, ***p <
0.0001, **p < 0.01, and *p < 0.05.
See also Figure S1.Thus, adecrease in thenumberand lengthof ventricularprimary
cilia, which are also often found within vesicles inside the cell,
strongly suggests defects in their formation inHeCo aRGs during
the early-to-middle (early-mid) stages of cortical development.
We also searched for potential primary cilia defects in
other neuronal progenitor types. Upon Arl13b immunostaining,
the E13.5 cortical wall of WT and HeCo mice was subdivided1598 Cell Reports 28, 1596–1611, August 6, 2019in six equally sized bins. An increased proportion of Arl13b
puncta was identified in upper-VZ/subventricular zone (SVZ)-
containing bin 4 (with a decrease in the SVZ/intermediate
zone [IZ]-containing bin 5) in HeCo cortices (Figures S1L
and S1M). These preliminary data may indicate that primary
cilia are also abnormal in other progenitors populating more
basal regions of the developing cortex.
Figure 2. Primary Cilia Formation Is
Impaired in Eml1 Mutant Conditions,
although No Changes in Shh Signaling
Were Observed
(A) Representative images of EM acquisitions of
the apical surface of WT and HeCo brains. White
arrow shows that the basal body is not properly
assembled in HeCo aRGs. Instead, densely
packed microtubules are observed. The black
asterisk indicates apically oriented primary cilium
within a vesicle. The white asterisk indicates
basally oriented primary cilium within a vesicle.
(B and C) Quantification of primary cilium length in
WT (n = 4 embryos from 3 litters, 25 primary cilia)
and HeCo (n = 5 embryos from 3 litters, 15 primary
cilia) VZ. Each point represents an embryo (B) or a
primary cilium (C).
(D and E) Percentage of primary cilia found within
vesicles in WT and HeCo VZ (D), and percentage
of basally oriented primary cilia in WT and HeCo
VZ (E). Each point represents an embryo (n = 5 per
condition from 3 litters; 150–169 cells). Statistical
tests were performed considering the frequency
across cells analyzed.
(F) Representative western blot of WT and HeCo
E13.5 cortical lysates immunodetected for Gli3
and GAPDH.
(G) Quantifications from E13.5 western blots, with
band intensities normalized to GAPDH (WT: n = 9
embryos from 2 litters; HeCo: n = 7 embryos from
2 litters).
(H) Representative western blot of WT and HeCo
E12.5 cortical lysates immunodetected for Gli3
and GAPDH.
(I) Quantifications from E12.5 western blots, with
band intensities normalized to GAPDH (WT: n = 10
embryos from 2 litters; HeCo: n = 8 embryos from
2 litters).
Scale bar, 0.5 mm (A). Box and whisker plots show
the median ± minimum-maximum range followed
by Mann-Whitney test (B and C) or chi-square test
(D and E) or mean ± SEM (G and I). ****p < 0.0001
and *p < 0.05.There Are No Major Changes in HeCo Cortex Shh
Signaling at Early-Mid Corticogenesis
Primary cilia are central for the transduction of Sonic hedgehog
(Shh) signaling (Wheway et al., 2018). Conditional knockout
mice of ciliary proteins often show changes in Shh signaling in
the developing brain impacting the levels and/or processing of
its downstream effectors, notably the Gli transcription factors
(Besse et al., 2011; Willaredt et al., 2008; Wilson et al., 2012).
Gli proteins are found in a short-length (SL) repressor form or
in a full-length (FL) activator form upon Shh stimulation. The pri-
mary cilium phenotype observed in HeCo aRGs prompted us to
analyze this pathway. We analyzed the levels of Gli3 in cortical
lysates from HeCo and WT mice at E12.5 and E13.5 by western
blot (Figures 2F–2I). There was a tendency toward a decreased
Gli3 full-length:Gli3 short-length ratio in HeCo cortices (Figures
2G and 2I) that was stronger at E13.5 than E12.5, the stage at
which the severest primary cilia phenotype was observed.
Despite these consistent subtle differences, there were no signif-icant Shh changes observed between HeCo and WT E12.5/
E13.5 cortical lysates.
Protein Partners of Eml1 Help Indicate that RPGRIP1L Is
a Heterotopia Gene
Eml1 appears to have crucial functions regulating aRG behavior
(Kielar et al., 2014; Bizzotto et al., 2017; this study), although the
molecular pathways in which it is involved have not yet been
clearly linked to aRG phenotypes. Performing a comprehensive
analysis of potential Eml1-interacting partners identified in a
previous screen (Bizzotto et al., 2017), the ciliary protein Rpgrip1l
was identified. This protein is known to localize to the base of the
primary cilium, in the transition zone, and mutations were previ-
ously identified in Joubert and Meckel ciliopathy syndromes
(Wiegering et al., 2018). To confirm the interaction between
Eml1 and Rpgrip1l, Neuro2A cells were co-transfected with
FLAG-tagged EML1 and c-myc-tagged RPGRIP1L plasmids.
48 h later, antibodies directed at the tag of one of the proteinsCell Reports 28, 1596–1611, August 6, 2019 1599
(e.g., anti-FLAG; Figure 3A) were incubated with cell lysates to
capture the protein of interest. Protein G Sepharose was added
to capture the antibody-protein complexes, and after elution,
these were then separated on protein gels. Immunodetection
of western blots was performed with antibodies directed against
the opposing protein tag (e.g., anti c-myc). Co-immunoprecipita-
tion (coIP) experiments were performed in both directions, and
this confirmed the interaction between EML1 and RPGRIP1L
with either anti-FLAG (Figure 3A) or anti-c-myc (Figure 3F) anti-
bodies used for the initial precipitation. These results further
support that EML1 may play a role in primary-cilium-related pro-
tein complexes.
Simultaneously, compound heterozygous variations in
RPGRIP1L (GenBank: NM_015272.2) were identified in a patient
(P700-5) with SH (Figures 3B–3D; Table S1). P700-5 also ex-
hibited agenesis of the corpus callosum and cerebellar dysplasia
(Figures 3D4 and 3D5; Table S2). Nucleotide variations in
RPGRIP1L were confirmed by Sanger sequencing. A
c.3706C>T pathogenic variation in exon 24 (R1236C, sorting
intolerant from tolerant [SIFT; https://sift.bii.a-star.edu.sg/]
0.03, damaging) was transmitted from the father. A c.3562G>A
nucleotide change in exon 22 (V1188M, SIFT tolerated) was
transmitted from the mother (Figure 3C; Table S1). Since auto-
somal recessive mutations in RPGRIP1L have previously been
associated with Joubert and Meckel syndromes (OMIM:
610937), the unusual C-terminal mutations identified here (Fig-
ure 3E) may be important for the cortical phenotype observed.
Given the interaction of EML1 and RPGRIP1L and the resem-
blance of the phenotypes found in patients, we postulated that
the interaction between these proteins may be altered in the
presence of patient mutations. Both individual RPGRIP1L muta-
tions led to a dramatic loss of interaction with EML1, using either
anti-FLAG or anti-c-myc (Figures 3F, 3G, S2A, and S2B) for
immunoprecipitation. The RPGRIP1L interaction was also tested
using an EML1 construct expressing a patient mutation (family
P135, mutation T243A; Kielar et al., 2014). Under these condi-
tions, dramatically reduced quantities of FLAG-EML1-T243A
were observed in anti-c-myc immunoprecipitates (Figure 3G).
These data confirm that when either RPGRIP1L or EML1 is
mutated, the interaction between the proteins is compromised.
These combined data suggest that convergent primary-cilia-
related mechanisms are responsible for the heterotopia in
EML1 and RPGRIP1L patients. We then assessed the localiza-
tion of RPGRIP1L mutant proteins in a human cell line (retinal
pigmented epithelial cells [RPE1 cells]). RPE1 cells were
transfected with recombinant c-myc-RPGRIP1L WT, c-myc-
RPGRIP1L-R1236C, or c-myc-RPGRIP1L-V1188M. While WT
RPGRIP1L clustered in perinuclear regions with a puncta-like
pattern (white box), as previously shown for this protein (Ger-
hardt et al., 2015), the same type of staining was not observed
when transfecting cells with the mutant constructs (Figure S2C).
This suggests an altered subcellular localization of RPGRIP1L
expressing heterotopia mutations.
To begin to test the impact of the individual RPGRIP1L heter-
otopia mutations at the early stages of corticogenesis, they were
overexpressed in WT mouse brain. In utero electroporation at
E13 was performed of individual c-myc-RPGRIP1L mutant con-
structs with a pCAG-IRES-GFP (pCAGIG) reporter construct to1600 Cell Reports 28, 1596–1611, August 6, 2019identify electroporated cells, as well as an Arl13b-RFP construct
targeting the primary cilium. At E14, Pax6+GFP+ cells were quan-
tified across six equally sized bins spanning the cortical wall, and
the percentage of cells in the region encompassing the VZ was
assessed (bins 1–3) compared to the SVZ, IZ, and cortical plate
[CP; bins 4–6; Figure S2D). Mutant forms of RPGRIP1L, espe-
cially the V1188M mutation, led to an apparent shift of
Pax6+GFP+ and Pax6+GFP cells to basal positions in the
cortical wall (Figure S2E). In addition, the c-myc-RPGRIP1L
V1188M construct showed the presence of polarized rosette-
like structures composed of primary cilia-containing Pax6+ cells
in abnormal superficial regions (two out of three embryos; Fig-
ure S2F). Internalization of Pax6+ cells has previously been asso-
ciated with primary cilia defects (Higginbotham et al., 2013; Lien
et al., 2006).
Primary Cilia Formation Is Impaired in EML1 and
RPGRIP1L Patient Fibroblasts
Convergent suggestions for a link between primary cilia and het-
erotopia led us to assess the growth dynamics of this organelle in
human patient fibroblasts. A cell culture approach for analyzing
primary cilia assembly and/or disassembly was adopted (Kher-
admand Kia et al., 2012). Five different lines of human fibroblasts
were cultured from two EML1-patients (P3489 and P135; Kielar
et al., 2014), the above-described RPGRIP1L-heterotopia
patient (P700), and two similarly aged controls (control 1 and
control 2). We studied primary cilium formation (1) under basal
conditions (72 h after plating), when cells are asynchronously
dividing; and (2) after serum starvation (SS), which was per-
formed for 48 or 96 h (Figures 4A–4E, S3A, and S3B). SS induces
cells to enter quiescence (G0) and thus grow a primary cilium
(Figure S3A).
The percentage of cells presenting a primary cilium in the three
different conditions was analyzed. Under basal conditions (Fig-
ure 4B) and 48 h after SS (Figure S3C), each of the three patient
lines showed significantly fewer cells possessing a primary
cilium. At 96 h, one of the EML1 patient lines (P3489) reached
levels similar to those of the control lines, while the other patient
lines continued to show a significantly decreased proportion of
primary-cilium-containing fibroblasts (Figure 4D). Under basal
conditions and 48 h after SS, primary cilia length did not seem
to be severely compromised compared to control lines (although
the P135 and P700 fibroblast lines showed a tendency to have
shorter primary cilia; Figures 4C and S3D). However, when per-
forming SS for 96 h, all patient lines showed a significant
decrease in the length of primary cilia compared to control con-
ditions (Figure 4E).
These results suggest that EML1- andRPGRIP1L-mutant cells
do not assemble cilia efficiently, in fitting with a role for EML1 and
RPGRIP1L in primary cilium formation. Importantly, RPGRIP1L
patient fibroblasts showed the same dynamics as EML1 patient
fibroblasts, further suggesting that perturbed mechanisms un-
derlying the heterotopia phenotype may converge.
Human Cortical Progenitors with EML1 Mutations Also
Show Primary Cilia Anomalies
We decided to further analyze primary cilia in human cortical
progenitor cells in vitro. These were differentiated from
Figure 3. EML1 Interacts with RPGRIP1L, in which Mutations Were Identified in a Heterotopia Patient
(A) Representative western blots showing immunoprecipitation with anti-FLAG when co-transfecting FLAG/FLAG-EML1 with c-myc-RPGRIP1L (3 experiments
per condition). The FLAG peptide alone (1 kDa) is a short sequence not recognized under these western blot conditions. Input: cell lysate prior to IP; UB (unbound)
corresponds to the fraction of proteins not attaching to the bait (here FLAG-tagged protein).
(B) Pedigree of the family (P700), with one healthy boy, one affected boy, and one miscarriage.
(C) Sanger sequence chromatograms for the parents and affected child of a portion of theRPGRIP1L gene. Compound heterozygous mutations were identified in
patient 700-5 (red arrows), one inherited from the mother and one from the father. Nucleotides are shown in red (T), black (G), green (A), and blue (C).
(legend continued on next page)
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iPSCs from two control individuals and two EML1-mutation
patients (controls 1.1 and 2.1, P3489, and P135; Figure S3E;
Kielar et al., 2014; Gaspard et al., 2008; Shi et al., 2012). EM
analyses of control-line-derived cortical cultures revealed
the presence of a mother centriole docking a properly arranged
primary cilium surrounded by ciliary pockets (Figure 4F).
When investigating primary cilia in patient-derived cortical
progenitors, we had difficulty identifying these organelles and
those primary cilia observed showed abnormalities, including
disturbed ciliary-like structures with no proper microtubule
arrangement (Figure 4F, P135) or ciliary pockets that appeared
distended (Figure 4F, P3489). Thus, the primary cilium also
appears perturbed in human patient-derived cortical progeni-
tors, suggesting a conserved role of Eml1/EML1 across
evolution.
Subcellular Localization and EML1-Interacting Proteins
Shed Light on Potential Pathways Involved in the
Centrosome-Primary Cilia Phenotype
EML1 has a cell-cycle-dependent localization in mouse neuronal
progenitor cells in vitro (Kielar et al., 2014). It co-localizes with the
microtubule network in interphase Vero cells (Kielar et al., 2014);
however, a ciliary localization has not been described for this
protein family (Fry et al., 2016). Its localization was hence further
explored in aRGs, as well as in ciliated RPE1 cells, using exoge-
nous expression of an EML1-tagged plasmid, since there are no
known reliable antibodies to detect the endogenous protein.
Transfection of YFP-EML1 in RPE1 cells showed recombinant
EML1 throughout the cytoplasm, including in perinuclear re-
gions, with no obvious association with the primary cilium (Fig-
ure S4A). In utero electroporation of pCAG-IRES-Tomato (to
delineate aRGmorphology) and EGFP-EML1 identified recombi-
nant EML1 ubiquitously expressed in aRG apical processes
(Figure S4B).
To learn more about EML1’s cellular role, we screened for
additional interacting partners using full-length EML1, differing
from the previous screen, which used only the N terminus (Biz-
zotto et al., 2017). Indeed, most mutations fall in the C-terminal
b propeller structure (Fry et al., 2016), indicating the potential
importance of this domain. Pull-down experiments were per-
formed with purified Strep-tagged full-length EML1 and E13.5
WT mouse cortex lysates (Figure 5A). Captured proteins were
identified by mass spectrometry (MS). Label-free quantitative
analyses based on the extracted ion chromatogram (XIC)
method revealed a list of 240 proteins enriched in the Strep-
tagged EML1 condition (Table S3). We compared this 240-pro-
tein list with the N-terminal interactors identified previously(D) Representative T1-weighted section of brainmagnetic resonance imaging (MR
spanning from the frontal lobe (D1) to the parieto-temporal region (D2). In the oc
periventricular subependymal heterotopia (D3, green arrow). Note that the overly
callosum agenesis (D4, red arrow) and cerebellar dysplasia (D5, blue arrow).
(E) Schematic representation of the RPGRIP1L gene (above) and protein domain
tations found in P700-5.
(F) Representative western blot of immunoprecipitation with anti-c-mycwhen co-
(3 experiments per condition).
(G) Quantification of immunoprecipitation experiments comparing the amount of E
was normalized to total levels of the protein and immunoprecipitated bait protein
See also Figure S2.
1602 Cell Reports 28, 1596–1611, August 6, 2019(Bizzotto et al., 2017). 85 out of 240 proteins commonly inter-
acted with both the EML1 N-terminus and the full-length protein,
confirming the specificity of the new screen (Figure 5 B). The re-
maining proteins may be specific for interactions with the EML1
C-terminal domain.
To further identify cytoplasmic proteins, the new 240-protein
list was further filtered to exclude nuclear proteins (as previously
performed in Bizzotto et al., 2017), and a final list of 113 proteins
was obtained (Table S3). The expression pattern across the mu-
rine developing cortex (E14.5) was examined for genes encoding
these proteins using publicly available resources (GenePaint
[https://gp3.mpg.de/]; data were available for 71 out of 113 pro-
teins; Figure 5C). 63.4% of the 113 proteins clearly showed
expression in the VZ (8.9% showed a CP expression only, and
a further 27.7% were of unknown expression).
Cilia-related proteins were identified in both N-terminal and
full-length lists (Table S4), revealing a total of 42 potential
cilia-related EML1 interactors. Gene Ontology (GO) analyses
for the 113-protein list were performed using the DAVID (Data-
base for Annotation, Visualization and Integrated Discovery
functional annotation tool [https://david.ncifcrf.gov/home.jsp])
and STRING (Search Tool for the Retrieval of Interacting
Genes/Proteins [https://string-db.org]) publicly available re-
sources (Figure 5D; Tables S4, S5, and S6). Cell-cell adhesion,
microtubule and actin-associated proteins, and Golgi-derived
protein transport were identified among other categories in
DAVID GO analyses (Figure 5D; Tables S4 and S5). STRING an-
alyses revealed similar results, including membrane-bounded
organelle, cytoskeleton, and cell junction among the most en-
riched ‘‘cellular component’’ GO categories (Table S6). Thus, in
addition to cilia proteins, several other categories of proteins
point to previously uncharacterized roles for EML1.
Golgi-Related Protein Partners of EML1, Including
VCIP135
The prominent apical process localization of recombinant EML1
in interphase aRGs, as well as the GO categories identified,
prompted us to further focus on protein trafficking from the Golgi
apparatus, localized in aRG apical processes (Taverna et al.,
2016).
Given the importance of cargo trafficking and Golgi-derived
protein transport for primary cilium formation, we searched
for Golgi-related proteins in the MS lists (Table S4). VCIP135
(also known as VCPIP1) showed high specificity for the
EML1-bound condition. This protein mediates Golgi apparatus
cisternae regrowth after mitosis as well as maintenance of this
organelle during interphase. Knockdown of VCIP135 is knownI) of P700-5 and control showing a unilateral, extensive, subcortical heterotopia
cipital lobe, the cortical malformation is characterized by right-sided nodular
ing cortex is thinner and appears dysplastic (D1–D3). P700-5 presents corpus
s (below). Blue arrows indicate the position of compound heterozygous mu-
transfecting (WT or mutant) FLAG-EML1 with (WT or mutant) c-myc-RPGRIP1L
ML1 bound to RPGRIP1L inWT andmutant conditions. The bound prey protein
. Data are represented as mean ± SEM.
Figure 4. Primary Cilium Formation Is Perturbed in EML1 and RPGRIP1L Patient Fibroblasts and Cortical Progenitors Differentiated from
EML1 Patient-Derived iPSCs
(A) Representative images of immunocytochemistry for g-tubulin (green) and Arl13b (red) in control (control 1 and 2) and patient fibroblasts (P3489: EML1W225R;
P135: EML1 T243A R138X; and P700: RPGRIP1L R1236C V1188M) at basal conditions (72 h) and 96 h after serum starvation (SS).
(B) Percentage of fibroblasts presenting a primary cilium in basal conditions (2–4 experiments per condition).
(C) Quantifications of primary cilium length in fibroblasts in basal conditions (n = 24–109 primary cilia from 2 to 4 experiments).
(D) Percentage of fibroblasts presenting a primary cilium at 96 h SS (3–4 experiments per condition).
(E) Quantifications of primary cilium length in fibroblasts at 96 h SS. n = 64–141 primary cilia from 3 to 4 experiments.
(F) Representative EM images of human cortical progenitors derived from control and EML1mutation patient iPSCs. Yellow arrow, basal body; blue arrow, ciliary
pockets; and red arrow, primary cilium.
Scale bars, 10 mm (A) and 0.5 mm (F). Data are represented as median ± minimum-maximum range and chi-square test (B and D) or mean ± SEM and one-way
ANOVA followed by unpaired t test (C and E). ****p < 0.0001, ***p < 0.001, **p < 0.01, and *p < 0.05.
See also Figure S3.
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Figure 5. Mass Spectrometry Analyses
Reveal Additional EML1-Interacting Part-
ners, among Them the Golgi Protein
VCIP135
(A) Schematic of the proteomics workflow. Either
Strep-YFP or Strep-YFP-EML1 purified with Strep-
Tactin beads was used for pull-down experiments
using embryonic cortex lysates. Binding partners
were obtained by quantitative label-free MS ana-
lyses performed from four replicates.
(B) Diagram indicating number of common proteins
identified in full-length and N-terminal (Bizzotto
et al., 2017) EML1 MS screens.
(C) Diagram representing expression of EML1-in-
teracting partners in the E14.5 murine cortical wall
(GenePaint).
(D) Gene Ontology analyses performed with the
publicly available software DAVID for the 113-pro-
tein list. Only those categories with an enrichment
score >1 are represented.
(E) Representative western blot of immunoprecipi-
tation with anti-FLAG when co-transfecting FLAG-
VCIP135 with Strep-YFP, Strep-YFP-EML1, GFP-
EML1, and GFP-EML1-T243A (2–3 experiments
per condition).
(F) Quantification of immunoprecipitation experi-
ments comparing the amount of EML1 bound to
VCIP135 in WT and mutant conditions. The bound
prey protein was normalized to total levels of the
protein and levels of the bait protein.
(G) Representative western blot of immunoprecip-
itation with Strep or GFP when co-transfecting
Strep-YFP with FLAG-VCIP135, Strep-YFP-EML1
with FLAG-VCIP135, GFP-EML1 with FLAG-
VCIP135, and GFP-EML1-T243A with FLAG-
VCIP135 (2–3 experiments per condition).
(H) Quantification of immunoprecipitation experi-
ments comparing the amount of VCIP135 bound to
EML1 in WT and mutant conditions. The bound
prey protein was normalized to total levels of the
protein and levels of the bait protein.
Data are represented as mean ± SEM (F and H).
See also Figures S4 and S5.to lead to Golgi fragmentation (Uchiyama et al., 2002; Zhang
et al., 2014; Zhang and Wang, 2015). The interaction of
Strep-tagged EML1 with FLAG-tagged VCIP135 was tested
by performing coIP experiments in Neuro2A cells. An interac-
tion was confirmed using either anti-FLAG or Strep for the IP
(Figures 5E and 5G). We next checked if EML1 mutation per-
turbed this interaction, performing coIP experiments with
GFP-EML1 T243A and FLAG-VCIP135. Using anti-FLAG and
anti-GFP, a reduction of the interaction between the two
proteins was observed (Figures 5E–5H). Therefore, a patient
mutation in the b propeller domain of EML1 disrupts the inter-
action with VCIP135, suggesting that EML1 may play a role
associated with the Golgi apparatus.1604 Cell Reports 28, 1596–1611, August 6, 2019We next decided to knock down
(KD) Vcip135 in aRGs at E13 (Figure
S5A), a time when ectopic aRGs are
found in Eml1 mutant conditions (Kielar
et al., 2014). A miRNA-embedded shorthairpin (shmiRNA) against Vcip135 and a scrambled control
shmiRNA (shmiRNA control) were generated. Efficiency
was tested (reduction by 40 %) by performing transfections
of these constructs in Neuro2A cells, followed by qRT-PCR
(Figure S5B). In utero electroporation together with a pCAG-
IRES-Tomato construct was performed at E13, and brains
were analyzed 24 h later (Figure S5A). Tomato+ cells were
quantified across six equally sized cortical bins. A significant
shift of Tomato+ cells was observed from bins 1 to 3 toward
more basal positions in the Vcip135 KD condition (Figure S5C).
This suggests that Golgi-related proteins, and more specifically
the Eml1-interacting protein Vcip135, are important for progen-
itor cell position.
Figure 6. The Golgi Apparatus Is Severely Disrupted in Eml1 Mutant aRGs in Brain Slices
(A) WT and HeCo aRGs electroporated with pCAG-IRES-Tomato (cell morphology) and pCAG-Galt-EGFP (Golgi apparatus).
(B) Schema representing the parameters quantified and the Golgi phenotype observed in aRGs.
(C) Quantification of number of Golgi elements.
(D) Quantification of Golgi extension.
(E) Quantification of the percentage of cells containing perinuclear Golgi elements. Statistical tests were performed considering the frequency across cells
analyzed.
(F) Quantification of the distance between the basal-most Golgi element to the aRG soma.
(G) Representative EM images of the Golgi apparatus in WT and HeCo aRGs at E13.5. Red arrow shows anastomosis.
(legend continued on next page)
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The Golgi Apparatus Is Severely Disrupted in HeCo
Neuronal Progenitors
A Golgi localization for recombinant Eml1 could not be easily
identified in Pax6+ neuronal progenitors due to the abundant
soluble fraction of the protein (Figure S4C). We decided to query
this organelle in HeCo aRGs. The Golgi apparatus has recently
been described to be restricted to aRG apical processes, where
it exists as a series of individualized stacks (Taverna et al., 2016),
defined here as ‘‘Golgi elements.’’ In utero electroporation of a
pCAG-IRES-Tomato plasmid, as well as a pCAG-Galt-EGFP
plasmid targeting the Golgi apparatus, was performed at E13,
and WT and HeCo brains were analyzed at E13.5. Golgi position
was assessed in WT and HeCo aRGs as in Taverna et al. (2016),
and the number of perinuclear Golgi elements was also
assessed.
Golgi apparatus distribution was strikingly different in HeCo
compared to WT aRGs at E13.5 (Figures 6A–6F). The number
of Golgi elements was significantly reduced, as was the exten-
sion of this organelle in the apical process (Figures 6C and 6D).
Consistently, there were fewer Golgi elements in perinuclear re-
gions, and these were further away from the soma (Figures 6E
and 6F). These data indicate that in the HeCo VZ the Golgi appa-
ratus is subdivided in fewer stacks and does not span as far
across the apical process of aRGs (depicted in Figure 6B).
In order to further examine the Golgi apparatus phenotype,
several parameters were assessed by EM (Figures 6G–6J). Golgi
cisternae width was significantly increased in HeCo aRGs (Fig-
ures 6G and 6H), and there was a tendency for increased vesi-
cles surrounding this organelle (Figure 6I). We also assessed if
the Golgi apparatus showed signs of anastomosis, a process
characterized by the fusion and aberrant branching of Golgi
cisternae. Indeed, there was a significant increase in the anasto-
mosis-presenting Golgi apparatus in HeCo compared to WT
aRGs (Figure 6G, red arrows, and Figure 6J). These abnormal
Golgi features point toward a pathological disruption of this
organelle.
The multiple Golgi apparatus phenotypes suggest there may
also be functional Golgi alterations in HeCo aRGs. An in vitro
approach was established to assess Golgi-derived trafficking
in aRG-like cells in culture. Pax6+ progenitor-enriched cell cul-
tures (Sun et al., 2011) were prepared from the dorsal telenceph-
alon of E13.5 WT and HeCo embryos (Figure 7A). These cells
were transfected with the thermosensitive vesicular stomatitis
virus G protein VSVts405-G-EGFP (VSVG-EGFP). This modified
protein is stored in the endoplasmic reticulum (ER)-Golgi com-
partments when cells are incubated at 39.5C. Upon incubation
at 32C, the protein starts to exit these compartments and is
trafficked toward the plasma membrane (Alterio et al., 2015;(H) Quantification of cisternae width.
(I) Quantification of the number of vesicles surrounding each Golgi apparatus.
(J) Quantification of the percentage of Golgi apparatus presenting anastomosis.
Each point in (C)–(F) represents an embryo (WT: n = 5 embryos from 3 litters, with
cells analyzed per embryo). Data in (D) and (F) are normalized by the apical proces
represents an embryo (n = 3 embryos per condition from 3 litters, with 4–12 cells
cells analyzed (J). Scale bars, 10 mm (A) and 0.5 mm (G). Data are represented a
maximum range and Fisher’s exact test (E and J). ****p < 0.0001, ***p < 0.001, a
See also Figure S4.
1606 Cell Reports 28, 1596–1611, August 6, 2019Bergmann, 1989). Using this approach combined with immuno-
cytochemistry for the Golgi marker GM130, VSVG-EGFP antero-
grade trafficking was analyzed 5 and 30 min after incubation at
32C (Figure 7B). The presence or absence of GFP+ puncta
outside the Golgi apparatus was assessed at these two time
points, and the number of puncta was quantified. As expected,
5 min after incubation at 32C, most of the VSVG-EGFP protein
was found within the Golgi both in WT and HeCo cells, with only
some sparse GFP+ puncta found in the cytoplasm (average of
two puncta per cell in both conditions; data not shown; Figures
7B and 7C). However, analyses at 30 min showed fewer HeCo
cells presenting GFP+ puncta outside of the Golgi (17%
decrease) (Figures 7B and 7D). This decrease was significant
when considering 2 GFP+ puncta/cell as the baseline (Figure 7E).
HeCo cells also showed a lower overall number of GFP+ puncta
compared to WT cells (Figure 7F). Our data hence converge to
suggest that Golgi apparatus structure and its anterograde
transport are perturbed in HeCo cells, with a reduction in post-
Golgi trafficking demonstrated in the VSVG-EGFP assay.
EML1 Patient Fibroblasts and Human Cortical
Progenitors Also Show Golgi Anomalies
We queried if the Golgi apparatus was also perturbed in EML1
patient fibroblasts. The Golgi marker TGN46 was assessed in
basal conditions (72 h), quantifying the number of Golgi frag-
ments as well as Golgi volume (Figures S5D–S5F). P135 patient
cells showed an increased number of Golgi fragments as well as
an increased volume, and the P3489 line showed similar ten-
dencies (Figures S5D–S5F).
We also assessed theGolgi apparatus by EM in human cortical
progenitors derived from either control or EML1 patient iPSCs
(Figure 7G). Control line-derived cortical progenitors exhibited a
flat cisternae-containing Golgi apparatus. This was, however,
not true for the EML1 patient samples. Here, we observed a sig-
nificant increase in the percentage of cells presenting vacuolized
Golgi (Figure 7G, red asterisk, and Figure 7H). Primary cilia de-
fects were previously found to be associated with anomalies of
Golgi-dependent processes (Hua and Ferland, 2018). EML1
mutant Golgi apparatus defects are hence likely to be associated
with the severe primary cilium defects identified.
DISCUSSION
Our study unravels an unprecedented role for Eml1/EML1 in pri-
mary cilia formation. Through a plethora of approaches, we
report severe anomalies in this organelle in Eml1/EML1 mutant
conditions and confirm an EML1 ciliary protein partner,
RPGRIP1L. We identified a first heterotopia patient presenting3–6 cells analyzed per embryo; HeCo: n = 4 embryos from 2 litters, with 2–11
s length to avoid bias due to interkinetic nuclear migration. Each point in (H)–(J)
analyzed per embryo). Statistical test performed considering frequency across
s mean ± SEM and unpaired t test (C, D, F, H, and I) or median ± minimum-
nd **p < 0.01.
Figure 7. Golgi Anterograde Trafficking Is
Perturbed in Eml1 Mutant Progenitors
In Vitro, and This Organelle Is Also Disrup-
ted in iPSC-Derived Cortical Progenitors
(A) Pax6 (green) immunostaining in primary cul-
tures of mouse neuronal progenitors from WT and
HeCo mice (E13.5).
(B) Neuronal progenitor cells were transfectedwith
VSVG-EGFP and incubated at 39C. They were
then incubated at 32C and fixed 5 or 30 min later.
Immunostaining with GM130 (red) was performed.
(C) Percentage of cells containing GFP+ puncta
outside the Golgi at 5 min.
(D) Percentage of cells containing GFP+ puncta
outside the Golgi at 30 min.
(E) Percentage of cells containing >2 GFP+ puncta
per cell outside the Golgi at 30 min.
(F) Number of GFP+ puncta per cell outside the
Golgi at 30 min.
(G) Representative EM images of the Golgi appa-
ratus in cortical progenitors derived from control or
EML1 patient iPSCs. Red asterisk shows va-
cuolized Golgi apparatus.
(H) Quantification of the percentage of Golgi ap-
paratuses containing vacuolized Golgi. 20–28
cells were analyzed for each condition.
Cultures in (C)–(F) are from at least 3 embryos from
2 litters (n = 13–19 cells per condition). Each point
in (C)–(E) represents an independent experiment.
Statistical tests were performed considering the
frequency across cells analyzed. Each point in (F)
represents a cell. Scale bars, 10 mm (A and B) and
0.5 mm (G). Data are represented as median ±
minimum-maximum range with Fisher’s exact test
(C, D, E, and H) or Mann-Whitney test (F). **p <
0.01, and *p < 0.05.
See also Figure S5.mutations in this gene, which was previously only associated
with Joubert and Meckel syndromes (Wiegering et al., 2018). It
is likely that the heterotopia phenotype reflects the consequence
of specific compound heterozygous mutations localized within
the RPGR-interacting domain (RID) of the protein. Heterotopia
mutations alter the interaction of RPGRIP1L with EML1 suggest-
ing a convergent role for mutations in these proteins in SH path-
ophysiology. Overexpression of individual RPGRIP1L mutations
also changes their subcellular localization and perturbs Pax6+
progenitor organization in the mouse brain. Furthermore, EML1
and RPGRIP1L patient fibroblasts show similar primary cilia
assembly defects. Thus, multiple indications link these gene
phenotypes.
Severe defects were identified in the centrosome-primary
cilium complex in HeCo aRGs, as well as in EML1 patient fibro-
blasts and cortical progenitor cells in vitro. These microtubule-
based organelles are known to be critical for regulating aRG
behavior, and when altered, severe brain and/or cortical malfor-Cell Remations can arise (Bizzotto and Francis
2015). Centrosomal proteins are mostly
associated with microcephaly (Bizzotto
and Francis, 2015; Uzquiano et al.,
2018), while defects in primary cilia havebeen associated with microcephaly, polymicrogyria, periventric-
ular heterotopia (PV), focal cortical dysplasia, and ciliopathies
(Ding et al., 2019; Gabriel et al., 2016; Kheradmand Kia et al.,
2012; Park et al., 2018; Sheen et al., 2004). Of interest, certain
rare mutations in OFD1, localized in the basal body and involved
in primary cilium formation, have been previously associated
with SH (Del Giudice et al., 2014). Our study further links the pri-
mary cilium to severe heterotopia conditions in mouse and hu-
man. Additionally, this is one of the few studies linking abnormal
primary cilia to epilepsy (Canning et al., 2018; Park et al., 2018), a
condition also suffered by patients with EML1 mutations.
Although this study focused on aRGs, it is also important to
study Eml1/EML1 function and primary cilia in other neocortical
progenitors, which may contribute to the pathology. Our prelim-
inary data concerning Arl13b distribution throughout the cortical
wall in HeCo brains suggest potential abnormalities in more
basal cortical regions likely to contain intermediate progenitors.
We have also shown previously that EML1 is expressed in theports 28, 1596–1611, August 6, 2019 1607
SVZ of the gyrencephalic ferret brain (Kielar et al., 2014), and a
more recent study confirmed its expression in basal RGs present
in this zone in the human developing cortex (Nowakowski et al.,
2017). Basal RG progenitors are thought to be crucial for neocor-
tical expansion and gyrification and may be affected in severe
cortical malformations (e.g., Bershteyn et al., 2017). It would
thus be relevant to study EML1 and cilia function in this cell type.
Related to EML1 location and subcellular function, we did not
identify its expression within the primary cilium in interphase
cells. We hence investigated the molecular and cellular mecha-
nisms that might be upstream of its insertion in the apical plasma
membrane. Searching for additional interactors, we identified an
appealing list of candidate partners that may play a role in the
phenotype. We focused on the Golgi apparatus, since cargo
sorting and trafficking are known to be critical for the correct for-
mation of the centrosome-primary cilium complex (Bernabe´-Ru-
bio and Alonso, 2017;Madhivanan andAguilar, 2014). In addition
to VCIP135, other Golgi-related proteins identified by MS were
shown to co-localize with this organelle (e.g., CK1d); be impor-
tant for its structure, morphology, and function (e.g., Scyl1,
Map4, Camsap3, and Clasp1/2); or mediate cilia-targeted pro-
tein transport (e.g., Arf4). It is worth noting that some MS part-
ners also showed ciliary localization and/or functions (e.g.,
Nup98 andNeurl4), and somewere even reported to be localized
both in the Golgi and in the centrosome-primary cilium (e.g.,
CK1d, Map4, and Usp9x) and be important for their structure
and/or function (e.g., Staufen2, KifC1, Kif7, and Macf1). Of
note, Rpgrip1l appears also to be partially localized outside the
cilia (Sang et al., 2011).
An interaction of EML1 with the Golgi protein VCIP135 was
confirmed by heterologous expression in Neuro2A cells. The
EML1 T243A patient missense mutation perturbs this interac-
tion, as well as the interaction with the ciliary protein RPGRIP1L.
To further confirm that aRG delamination in mutant conditions is
related to these reduced interactions, rescue experiments with
WT and mutant EML1 protein could be performed.
VSVG data also point toward a cargo sorting and/or trafficking
defect in HeCo Pax6+ cells in vitro. Furthermore, the Golgi appa-
ratus in Eml1/EML1mutant conditions shows an abnormal distri-
bution and structure in mouse aRGs, patient fibroblasts, and
human cortical progenitor cells. We hence have convincing cu-
mulative evidence that this organelle normally requires Eml1/
EML1 in these cell types. Correct Golgi-derived function is also
critical for primary cilium formation (Bernabe´-Rubio and Alonso,
2017; Madhivanan and Aguilar, 2014), which leads us to suggest
that these Golgi phenotypes may be upstream of the centro-
some-primary cilium defect identified in Eml1/EML1 mutant
conditions.
Previous studies have tentatively associated Golgi defects
with cortical migration malformations, such as ARFGEF2 muta-
tions leading to microcephaly and PV (Sheen et al., 2004) and
DYNC1H1 mutations mainly leading to posterior pachygyria,
polymicrogyria, and microcephaly (Schiavo et al., 2013). How-
ever, experiments reporting Golgi apparatus anomalies in the
context of mutations in these two proteins were performed
in vitro and not directly in neuronal progenitor cells (Fiorillo
et al., 2014; Jaarsma and Hoogenraad, 2015; Sheen et al.,
2004). Instead, we assessed the Golgi in neuronal progenitor1608 Cell Reports 28, 1596–1611, August 6, 2019cells (human and mouse), including in mouse aRGs in vivo,
and were able to link Golgi anomalies to the pathogenesis of
severe SH.
It remains tobeelucidated if theGolgi functionsaltered inEml1/
EML1mutant conditions impact exclusively the centrosome-pri-
mary cilium pathway. If Golgi-dependent protein transport is
more widely perturbed, then it could also affect the delivery of
key adherens junction components to the plasma membrane,
which is crucial for aRG polarity and behavior (Sheen et al.,
2004; Uzquiano et al., 2018). This could loosen cell contacts be-
tween aRGs, allowing their delamination and contributing to the
ectopic progenitor phenotype. Further experiments are thus
required to understand the possible mechanisms related to
Golgi-plasmamembrane phenotypes inEml1/EML1mutant con-
ditions, as well as in other cortical malformation models.
Several signaling pathways integrated by the primary cilium
(i.e., mTOR, Shh, Hippo, and Wnt; Wheway et al., 2018) might
be expected to be disrupted in Eml1/EML1 mutant conditions.
For instance, changes in the mTOR signaling pathway have
been previously associated with diverse pathological cortical
phenotypes (Benova and Jacques, 2019; D’Gama et al., 2017;
Foerster et al., 2017; Park et al., 2018). However, we did not
find changes in this pathway in the HeCo telencephalon during
the early-mid corticogenesis (data not shown). We also did not
find any major changes in Shh signaling in HeCo dorsal telen-
cephalon extracts during the same stages. Nevertheless, other
approaches examining these pathways in aRGs specifically
would be necessary to completely rule out their implication in
the onset of the ectopic progenitor and thus heterotopia
phenotype.
Assessing other pathways known to be mediated by the pri-
mary cilium could also help shed light on the downstream path-
ological mechanisms contributing to progenitor phenotypes.
Another pathway associated with the primary cilium is the Hippo
pathway (Wheway et al., 2018), although the relationship re-
mains relatively unexplored. This pathway is known to regulate
tissue homeostasis and hence to regulate cell growth, size,
and shape (Ma et al., 2019). Primary cilium defects combined
with changes in apical domain and endfeet features, as well as
metaphase cell shape (this study; Bizzotto et al., 2017) make
this pathway an appealing candidate underlying abnormal VZ
dynamics in Eml1 mutant conditions. Mutations in proteins
involved in Hippo signaling have been previously associated
with cortical malformations (Cappello et al., 2013; O’Neill et al.,
2018). A recent study in the mouse also reported changes in
the levels of key Hippo pathway proteins in the VZ of a model
for SH, largely phenocopying the HeCo mouse phenotype (Liu
et al., 2018). Therefore, assessing this pathway in Eml1 mutant
conditions would shed further light on the molecular mecha-
nisms downstream of the primary cilium aRG phenotype.
In this study, we focused on the role of Eml1/EML1 during
interphase; however, this protein can play various roles during
the cell cycle (Bizzotto et al., 2017). This is consistent with the
extra-ciliary role of many proteins important for the centro-
some-primary cilium (Hua and Ferland, 2018). Further studying
the function of Eml1 and its ciliary protein partners during
different stages of the cell cycle will shed further light on
their multivalent roles in dividing cortical progenitors. During
interphase, our data are consistent with the fact that fewer Eml1
mutant aRG endfeet form cilia, potentially due to abnormal ciliary
protein targeting. Eml1 mutant aRG processes are hence defi-
cient, either through abnormal signaling or via weakened mem-
brane attachments due to abnormal adhesion component
trafficking. We propose that these mechanisms contribute to
progenitor delamination, initiating a sequence of events leading
to heterotopia.STAR+METHODS
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Mouse anti-g tubulin Sigma T6557; RRID: AB_477584
Rabbit anti-Arl13b Proteintech 17711-1-AP; RRID: 2060867
Mouse anti-GFP Sigma G6539; RRID: AB_259941
Rabbit anti-GFP Invitrogen A6455; RRID: AB_221570
Rabbit anti-Flag Sigma F7425, RRID: AB_439687
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Mouse anti-c-myc Cell Signaling Technology 9B11; RRID: AB_10889248
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Donkey anti-goat Alexa 568 Thermo Fisher Cat#A-11057; RRID: AB_142581
Goat anti-rabbit Alexa 488 Thermo Fisher Cat#A-11008; RRID: AB_143165
Goat anti-mouse Alexa 555 Thermo Fisher Cat#A32727; RRID: AB_2633276
Goat anti-rat Alexa 568 Thermo Fisher Cat#A-11006; RRID: AB_141373
Donkey anti-rabbit Alexa 647 Thermo Fisher Cat#A-31573; RRID: AB_2536183
Bacterial and Virus Strains
5-alpha competent E. coli NEB Cat#2988J
CytoTune-iPS 2.0 Sendai Reprogramming Kit Thermo Fisher A16517
Biological Samples
Human fibroblasts Coriell Biorepository N/A
Research center project SFB636 B7
Cell Bank Necker Hospital
Cell Bank Cochin Hospital
Erasmus Medial Center Cell Bank
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Critical Commercial Assays
QuikChange Lightning Site-Directed
Mutagenesis kit
Agilent Technologies Cat#210518
Lipofectamine 2000 Invitrogen Cat#11668030
Lipofectamine 3000 Invitrogen Cat#L3000001
Maxi prep kit Macherey-Nagel Cat#740410.10
NimbleGen chip 720,000-probes array Roche-NimbleGen N/A
SureSelect Human All Exon Kit v5 Agilent Technologies N/A
Micro BCA Protein Assay Kit ThermoFisher Cat#23235
Polyethylenimine Polysciences Cat#23966-1
Strep-Tactin beads Superflow Plus QIAGEN Cat#30002
RSLCnano system ThermoFisher Ultimate 3000
Epoxy resin PolySciences EPON218
3500xL Genetic Analyzer for Human Identification ThermoFisher Cat#4406016
NanoViper Acclaim PepMap 100 ThermoFisher N/A
5-bromo-20-deoxyuridine (BrdU) Sigma B9285
Deposited Data
PRIDE: PXD012714 Perez-Riverol et al., 2019 https://www.ebi.ac.uk/pride/archive/
Experimental Models: Cell Lines
Human: hTERT RPE1 ATCC N/A
Mouse: Neuro2A ATCC N/A
Human: FreeStyle 293 ATCC N/A
Experimental Models: Organisms/Strains
Mouse: HeCo NORCD1 Croquelois et al., 2009;
Kielar et al., 2014
N/A
Mouse: Swiss Janvier Labs N/A
Oligonucleotides
RPGRIP1L-ex24-R This paper 50 GCCTCCCAGGTATCTGGG 30
RPGRIP1L-ex22-F This paper 50CAGTAGTGTACATTGCATTC 30
RPGRIP1L-ex22-R This paper 50 TCTCTCTGTTCTTTCCACTTC 30
RPGRIP1L-ex24-F This paper 50 CTTAGAAAGTGGATTAGTGTTC 30
RM1_Vcpip1 KiCqStart, Sigma 50 GGAAAAGTACAATGTTTGCC 30
FW1_Vcpip1 KiCqStart, Sigma 50 GCTACATTAATGGGAGAAGAC 30
Recombinant DNA
VSVts405-G-EGFP B. Goud lab N/A
CMV-3xFlag-EML1 Kielar et al., 2014 N/A
CMV-3xFlag-EML1 T243A Kielar et al., 2014 N/A
pCAG-Galt-EGFP Kimura and Murakami, 2014 N/A
pEGFP-C3-EML1 Kielar et al., 2014 N/A
pEGFP-C3-EML1 T243A Kielar et al., 2014 N/A
pCS2-c-myc-RPGRIP1L Delous et al., 2007 N/A
pCS2-c-myc-RPGRIP1L R1236C This paper N/A
pCS2-c-myc-RPGRIP1L V1188M This paper N/A
CMV-3xFlag-VCIP135 Zhang and Wang, 2015 N/A
pMAX-Strep-YFP-EML1 Richards et al., 2014 N/A
pCAGMIR30-shRNA scramble This paper 50 TCCTAATTTCCGTGTGACAGT 30
pCAGMIR30-shRNA Vcip135 This paper 50 TTGTGCCTCAGGACCTTATTA 30
pMAX-Strep-YFP This paper N/A
(Continued on next page)
Cell Reports 28, 1596–1611.e1–e10, August 6, 2019 e2
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
pCAGIG Kielar et al., 2014, Addgene N/A
pCAG-Arl13b-RFP Jung et al., 2016 N/A
pCAG-IRES-Tomato C. Lebrand lab N/A
Software and Algorithms
Prism GraphPad software N/A
Tissue Analyzer Aigouy et al., 2010 https://imagej.nih.gov/ij/
Cell Profiler Cell Profiler, Lamprecht et al., 2007 https://cellprofiler.org/
Fiji/ImageJ Fiji/ImageJ https://fiji.sc/
Unified Genotyper GATK https://software.broadinstitute.org/gatk/
Polyweb University Paris Descartes N/A
Imagine Institute
Proteome discoverer version 2.1 ThermoFisher N/A
MyProms Poullet et al., 2007 N/A
MassChroQ version 1.2 Valot et al., 2011 N/A
CRAPome Mellacheruvu et al., 2013 http://crapome.org/
Burrows Wheeler Aligner SourceForge https://sourceforge.net/projects/bio-bwa/files/
PolyPhen-2 PolyPhen-2 http://genetics.bwh.harvard.edu/pph2/
SIFT Sorting Intolerant From Tolerant https://sift.bii.a-star.edu.sg/LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Fiona
Francis (fiona.francis@inserm.fr).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Research was conducted according to national and international guidelines (EC directive 2010/63/UE, French MESR 00984.02) with
protocols followed and approved by the local ethical committee (Charles Darwin, Paris, France). HeCo mutant mice arose sponta-
neously in a colony of NOR-CD1 outbred stock, and selective inbreeding including crossing of living relatives and backcrossing were
used to increase the occurrence of the phenotype in offspring as described in Croquelois et al., 2009. WT and HeCo mice derived
from regularly crossed colonies were used for all the experiments described. The mode of inheritance of the phenotype is autosomal
recessive. Normal, full-length transcripts of Eml1 are absent in HeCo brains due to the insertion of an early retrotransposon (ETn) in
the last intron of the gene, and are replaced by trace levels of shortened and chimeric Eml1-ETn transcripts (Kielar et al., 2014). Due to
the lack of good Eml1 antibodies (8 different antibodies tested) we were unable to verify for residual abnormal protein. Timed-preg-
nant Swiss mice obtained from Janvier Labs (https://www.janvier-labs.com/) were used to prepare embryonic cortex lysates for
mass spectrometry experiments as well as for in utero electroporation experiments. For staging of embryos, the day of vaginal
plug was considered E0.5. Mice were housed with a standard 12 h light/dark schedule (lights on at 07:00 a.m.). Male and female em-
bryos were used for all the experiments.
Human Cell Culture
Research on human cells was approved by the FrenchMinistry of Health (L.1243.3, DC-2015-2559). The CIMH has ethical agreement
for patient recruitment with respect to neurodevelopmental disorders and healthy controls. Patients involved were provided
with detailed information about the study and gave written informed consent before being included in the study. All experiments
with humanmaterial are in accordance with the declaration of Helsinki. The genetic analysis performed was subject to informed con-
sent procedures and approved by the Institutional Review Boards at Necker Enfants Malades Hospital and Paris Descartes
University.
Heterotopia Patients with Mutations in EML1
P135 and P3489 giant heterotopia male patients were as described in Kielar et al., 2014. R138X and T243A compound heterozygous
EML1 mutations were identified in patient P135. Homozygous W225R mutations were detected in patient P3489.e3 Cell Reports 28, 1596–1611.e1–e10, August 6, 2019
Clinical Phenotype of the Patient P700-5
P700-5 is a child of non-consanguineous Caucasian parents and was born at termwith normal neonatal parameters. The patient was
brought to medical attention at the age of 4, for developmental delay, secondary generalized focal seizures and left hemianopsia.
During infancy, epilepsy became drug-resistant, with at least one seizure type consisting of left hemibody tonic seizure, with expres-
sion of fear, followed by left clonic movement for 30 s. Seizure frequency is up to 2 per day, in spite of multiple anti-epileptic drug
combinations.
At last evaluation at 15 years of age, P700-5 presented moderate intellectual disability. He attended a specialized school, was able
to read andwrite fluently, although showed difficulties inmemorization. P700-5 is right handed. On examination, he demonstrated left
hemiplegia, is able to walk but is extremely fatigable, and so uses a wheelchair in everyday life. He shows impaired oculo-manual
coordination with oculo-cephalic apraxia associated with left hemianopsia.
On MRI performed at the age of 7 years, 7 months, P700-5 showed right subcortical heterotopia spanning the whole right hemi-
sphere, surrounded by fronto-parieto temporal polymicrogyria, associated with almost complete corpus callosum agenesis and
cerebellar dysplasia affecting the superior cerebellar vermis (Table S2).
Human Fibroblast Cultures
Skin biopsies were obtained with consent to isolate dermal fibroblasts using standard practices. Control 1 and control 2 have a male
origin. Fibroblasts from P3489, P135 and P700-5 also have a male origin. Human fibroblasts were cultured in Dulbecco Modified
Eagle Medium (DMEM) + GlutaMax (31966-021, Thermo Fisher) supplemented with 10% fetal bovine serum (FBS) and 50 mg/ml
of primocin (Invivogen). Before splitting, the cells were washed with Hanks-Balanced Salt Solution (HBSS) followed by incubation
for 3-5 minutes at 37Cwith a 0.25% (w/v) Trypsin, 0.53 mM EDTA, PBS 1x solution. Then 33 10 4 cells were plated on 14 mm glass
coverslips previously coated with Poly-L-Lysine 1x (PLL, Sigma Aldrich) O/N at 37C, followed by extensive washing with sterile
water. For serum starvation experiments, the cells were split, plated (3 3 104 in previously coated 14 mm coverslips) and cultured
for 24h in complete medium. After 24h, the cells were cultured in the same medium without FBS.
Generation of Human iPSCs and Thereof Derived Cortical Progenitors
Skin fibroblasts were either obtained from the Coriell Biorepository (Ctrl2: catalog ID GM08680, male origin), or derived with given
informed consent from a healthy donor within the collaborative research center project SFB636 B7 (Ctrl1: id-number B7_028#4, fe-
male origin) or from 2 well characterized EML1-patients (P3489 and P135, males, for more details see above and Kielar et al. [2014]).
Fibroblasts were reprogrammed by non-integrative delivery of OCT4, SOX2, KLF4 and c-MYC using Sendai virus (SeV) vectors (Ban
et al., 2011; Ethics Committee II of Heidelberg University approval no. 2009-350N-MA for hiPSC generation). Pluripotent stem cells
were validated and maintained as described (Iefremova et al., 2017). In brief, pluripotency was confirmed by the expression of plu-
ripotency-associated markers and three germ layer differentiation potential. The genomic integrity was validated by whole-genome
single nucleotide polymorphism (SNP) genotyping and iPSCs were maintained under standard culture conditions.
Differentiation of iPSCs into cortical progenitors was performed as described with slight adaptations (Shi et al., 2012; Iefremova
et al., 2017). In brief, iPSCs were cultured in PluriPro medium (Cell Guidance Systems). Once the cell culture reached 98% conflu-
ence, neural induction was initiated by changing the culture medium to neural induction media containing DMEM/F12 (N2 supple-
ment, 1:50; B27 supplement, 1:50), cAMP (300 ng/ml, Sigma-Aldrich), LDN-193189 (0.5 mM, Miltenyi), A83-01 (0.21 mg, Miltenyi)
and XAV939 (2mM, Enzo). Cells were maintained in this medium for 8–11 days, collected by dissociation with TrypL Express (Invitro-
gen) and replated in neural differentiation media containing DMEM/F12 (N2 supplement, 1:50; B27 supplement, 1:50) and cAMP
(300 ng/ml, Sigma Aldrich) onGeltrex-coated (GT, Life Technologies) plastic dishes. Cortical identity was validated bymarker expres-
sion. These cells homogeneously express the neural stem cell marker SOX2 as well as the forebrain markers FOXG1 and OTX2 and
the dorsal marker PAX6 (Figure S3 E, see below). Cells were split in a 1:2 ratio when cultures reach 100% confluence using TrypL
Express (Invitrogen). EM analyses were performed between passage one – three. See also Figure S3.
Retina Epithelial Pigmented Cell Culture
Retina Epithelial Pigmented (h-TERT RPE-1, female origin) cells were cultured in DMEM:F12 medium (30-2006, ThermoFisher) com-
plemented with 10% FBS at 37C and 5% CO2. Before splitting the cells were washed with Hanks-Balanced Salt Solution (HBSS)
followed by incubation for 3-5 minutes at 37C with a 0.25% (w/v) Trypsin, 0.53 mM EDTA, 1 x PBS solution.
Mouse Neuronal Progenitor Cell Culture
The neuronal progenitor cell culture was adapted from Sun et al., 2011. Briefly, 6-well cell culture plates were coated with Poly-D-
lysine (PDL, P6407, Sigma Aldrich) 2 mg/cm2 in sterile 1 x PBS, O/N, at 37C and 5% CO2. The following day, the PDL was removed,
and the plates were coated with 1 mg/cm2 fibronectin (F1141, Sigma Aldrich) in sterile 1 x PBS. E13.5 timed-pregnant mice were
sacrificed by cervical dislocation and the uterus was placed in ice cold basal medium (DMEM/F12 Hams, 21041, Thermo Fisher,
1% Pen-Strep (GIBCO), 2.9 mg/ml glucose and 1.2 mg/ml sodium bicarbonate). The embryos (males and females) were extracted
from the uterus one by one and the cortex from both hemispheres was dissected and kept at 4C in basal medium. The medium was
removed and substituted by pre-warmed sterile complete medium (basal medium complemented with 1 x B27 without vitamin A
(12589-010, GIBCO), 20 ng/ml of EGF (E9644, SigmaAldrich) and 20 ng/ml of FGF (F0291, Sigma Aldrich). The tissuewas dissociatedCell Reports 28, 1596–1611.e1–e10, August 6, 2019 e4
and each sample was centrifuged (3 min, 100 rcf.). The medium was removed and substituted by fresh pre-warmed complete me-
dium followed by re-suspension of the cells. 1 3 10 5cells were plated in coated 6-well culture plates.
Neuro2A Cell Culture
Cells were cultured in 10% FBS-supplemented DMEM (ThermoFisher) at 37C and 5% CO2. Cells were dissociated with 0.025%
trypsin–EDTA (25300-054, GIBCO) diluted in DMEM and plated into 100 mm Petri dishes (1 3 106/dish). Neuro2A cells have a
male origin.
Freestyle 293F Cell Culture
293F cells were cultured in FreeStyle 293 Expression Medium (ThermoFisher), under constant agitation, at 37C and 8%CO2. These
cells have a female origin.
METHOD DETAILS
En Face Immunohistochemistry and Imaging
En face immunohistochemistry (IHC) was performed as described in Bizzotto et al., 2017. F-actin immunodetection was performed to
delineate cell boundaries (Marthiens et al., 2010), combined with centrosome and primary cilium markers (g-tubulin and Arl13b,
respectively), as a means of further identifying apical endfeet. Briefly, mouse embryonic brains were fixed in 4% w/v paraformalde-
hyde (PFA) (Sigma-Aldrich, France). Cortical explants were dissected and incubated 15min at RT in PBST 1% (PBS 1X containing 1%
Triton X-100 v/v and 0.02% sodium azide). Explants were then incubated 2 hours (h) at room temperature (RT) in blocking solution
(PBS 1X, 0.3% Triton X-100 v/v, 0.02% sodium azide, 3% w/v Bovine Serum Albumin). Primary antibodies mouse anti-g-tubulin
(GTU-88, T6557, Sigma-Aldrich, 1:500) and rabbit anti-Arl13b (17711-1-AP, Proteintech, 1:500) were applied O/N at RT. After exten-
sive washing in blocking solution, explants were incubated O/N at RT with secondary antibodies anti-mouse Alexa 488 and anti-rab-
bit Alexa 568 (1:1000, ThermoFisher) together with Hoechst (1:1000, ThermoFisher). Washeswere performed in blocking solution and
PBST 1%, and then the explants were incubated with Alexa Fluor 633 Phalloidin (1:100, Life Technologies) in PBST 1% O/N at RT.
Extensive washing was performed in PBST 1% and PBS 1X before mounting the explants with Fluoromount G (Invitrogen) with the
ventricular surface (VS) up to obtain an en face view of the ventricular side of the cortex. Fluorescently stained sections were imaged
with a confocal TCS Leica SP5-II microscope.
Electron Microscopy
Mouse Embryos
Mouse embryos were transcardially perfused with a solution containing 4% PFA (Electron Microscopy Science), 2.5% glutaralde-
hyde in sodium phosphate buffer (PB) 0.1 M, pH 7.4. 3 h after perfusion, brains were dissected and post-fixed in the same solution
O/N at 4C. The samples were washed extensively with PB 0.1M, and afterward 3x 10 min washes with Palade buffer (Palade, 1952)
were performed. The samples were incubated in 2% osmium tetroxide in Palade buffer for 40 min at RT, and then rinsed in Palade
buffer for 3 min, followed by another 3 min wash in distilled water. They were dehydrated in a series of ethanol baths and flat-
embedded in epoxy resin (EPON 812, Polysciences). After polymerization, blocks containing the dorsal telencephalon were cut at
70 nm thickness using an ultramicrotome (Ultracut E Leica). Sectionswere cut with a diamond knife and picked up on formvar-coated
200 mesh nickel one slot grids. Digital images were obtained with a CCD camera (Gatan Orius).
Human neuronal progenitor cells
Cells were fixed for 1 h in PB0.1Mbuffer containing 4%PFAand 2.5%glutaraldehyde at 4C. Following fixation, cells were postfixed in
2% osmium tetroxide diluted in 0.2MPalade buffer (Palade, 1952). After osmication, cells were dehydrated in a series of ethanol baths
and flat-embedded in epoxy resin (EPON 812, Polysciences). After resin polymerization, small pieces were dissected from flat-
embedded cultures, mounted in plastic stubs and sectioned. Ultrathin sections (70 nm) were stained with uranyl acetate and lead cit-
rate. Sectionswere examined in a Philips CM100 electronmicroscope. Digital imageswere obtainedwith aCCDcamera (GatanOrius).
Exome Sequencing of Heterotopia Patients: Analyses of RPGRIP1L Mutations
Prior to exome analysis, for each patient, DNA was analyzed by CGH-microarray using the NimbleGen chip 720,000-probes (720 K)
array (Roche-NimbleGen, Madison, WI) to exclude potential pathogenic CNVs.
Whole exome sequencing of peripheral blood DNA from the proband and both parents was performed using the Agilent SureSelect
Human All Exon Kits v5, and sequences were generated on a HISeq2500 machine (Illumina). Sequences were aligned to hg19 by
using BWA v.0.6.1, and single nucleotide variants (SNVs) and indels were called by using GATK v.1.3. Annotation of variants was
performed with GATK Unified Genotyper. All calls with read coverage of % 2 3 or a Phred-scaled SNP quality score of % 20
were removed from consideration. The annotation process was based on the latest release of the Ensembl database. Variants
were annotated and analyzed using the Polyweb software interface designed by the Bioinformatics platform of University Paris Des-
cartes and Imagine Institute.
Filters used for variant screening were as follows: (i) all variants previously observed (in dbSNP138 and/or in in-house projects)
were excluded; (ii) only variants leading to abnormal protein sequence (splicing, non-synonymous, frameshift, stop) were retained;e5 Cell Reports 28, 1596–1611.e1–e10, August 6, 2019
(iii) we considered the PolyPhen-2 and SIFT prediction status as informative but not restrictive. Because the patient was a sporadic
case from unrelated parents, the following models of inheritance in the variant screening were considered: autosomal recessive (in
particular compound heterozygous but without excluding homozygous variants), X-linked and de novo SNVs.
A compound heterozygous mutation in RPGRIP1L was identified in a patient with subcortical heterotopia (P700; a c.3562G>A
nucleotide mutation in exon 22 was transmitted from the mother and c.3706C>T nucleotide mutation in exon 24 was transmitted
from the father, Table S1). Genomic DNA amplifications were performed for RPGRIP1L using standard procedures (RPGRIP1L-
ex22-F: 50CAGTAGTGTACATTGCATTC 30 ; RPGRIP1L-ex22-R: 50 TCTCTCTGTTCTTTCCACTTC 30 ; RPGRIP1L-ex24-F: 50 CTTA
GAAAGTGGATTAGTGTTC 30 ; RPGRIP1L-ex24-R: 50 GCCTCCCAGGTATCTGGG 30), and PCR products were analyzed by direct
sequencing using an 3500xL Genetic Analyzer (Applied Biosystems, Foster City, CA).
Embryonic Cortex Lysate
Formass spectrometry experiments E13.5 timed-pregnant Swissmice (Janvier Labs, France) were sacrificed by cervical dislocation.
Embryos were dissected and both brain hemispheres collected in ice cold L-15 medium. Explants were immediately frozen in liquid
nitrogen and ground into a powder. Hemispheres from different embryos were pooled. The powder was re-suspended in 10 ml/mg
lysis buffer (Tris HCl 50 mM, NaCl 150 mM, EDTA 1 mM pH 8) supplemented with NP-40 1% and protease inhibitors 1x (Complete
Protease Inhibitor Cocktail Tablets EDTA-Free, Roche). The lysate was homogenized by rotation during 45 min at 4C, then centri-
fuged for 30 min at 15000 rcf. and 4C. The supernatant was collected and stored at 80C.
For western blot experiments designed to study the Shh signaling pathway the protocol was mildly modified. Once the cortex was
dissected and fast-frozen in liquid nitrogen, lysis of each embryonic cortex (from both hemispheres) was performed individually, by
re-suspending the tissue continuously with lysis buffer for a period of 2 h at 4C. Then the lysate was centrifuged (30 min, 15000 rcf.,
4C), the supernatant collected and protein concentration measured using the BCA Protein Assay Kit (Thermo Fisher) and the ELISA
microplate reader BertholdTech Mithras.
hTERT RPE-1 Cell Transfection
6 3 10 4 cells were plated in previously coated 14 mm glass coverslips (PLL, 10 min RT, followed by extensive washing with sterile
water). 24 h later, cells were transfected with a ratio of 1:4 DNA and lipofectamine 2000 (Invitrogen). 2 ml of lipofectamine were com-
bined with 50 ml of OPTI-MEM Media (ThermoFisher). In parallel 0.5 mg of DNA were combined with 50 ml of OPTI-MEM. The latter
solution wasmixed with the former and after 20 min at RT, the mix was applied to the cells. 24 h after transfection the cells were fixed
and immunostained (see below).
Freestyle 293F Cell Transfection, Protein Purification, and Pull Down for Mass Spectrometry
For transfection, 13 10 6 cells were cultured in a 125 mL Erlenmeyer. 45 mg of Polyethylenimine (PEI, Polysciences) were mixed with
750 ml of OPTI-MEM (ThermoFisher) and 22.5 mg of DNA with 750 ml of OPTI-MEM, for a 1:2 ratio of DNA: PEI. The DNA was mixed
with the PEI solution and after a period of 10 min at RT the mix was applied to the cells. 72 h later the cells were recovered, washed
with 1 x PBS and lysed with 750 ml of lysis buffer (Tris HCl 50mM, NaCl 150mM, EDTA 1mMpH 8) supplemented with NP-40 1%and
protease inhibitors 1X (Complete Protease Inhibitor Cocktail Tablets EDTA-Free, Roche). After 30 min of rotation at 4C, the samples
were centrifuged for 15 min, 14.000 rcf., at 4C. The supernatant was kept and protein content was measured with the BCA Protein
Assay Kit (ThermoFisher) and the ELISA microplate reader BertholdTech Mithras, in order to ensure similar protein concentrations
across the different conditions.
For protein purification, Strep-Tactin beads Superflow Plus (30002, QIAGEN) were used. 40 ml of beads previously washed with
lysis buffer were used for each purified protein sample. They were incubated with 2 mg of protein lysate (in a 100 ml volume) for
1 h at 4C under rotation. The samples were then centrifuged (3 min, 200 rcf., 4C), and the supernatant was kept as the ‘unbound’
fraction. The beads were washed (3x) with a more stringent lysis buffer containing 500 mM NaCl, in order to eliminate possible pro-
teins binding to the beads in a non-specific fashion. For control experiments to check correct protein purification, elution was per-
formed with NuPAGE LDS Buffer (ThermoFisher). For pull down samples to analyze by mass spectrometry (n = 4/condition), the
Strep-Tactin beads already bound to the protein of interest (Strep-YFP or Strep-YFP-EML1) were incubated with 15 mg of cortex
lysate (described above) O/N, at 4C, under rotation. Then the samples were centrifuged (3 min, 200 rcf., 4C), and the ‘unbound
cortex’ recovered. The beads containing the purified protein of interest and its interacting partners were extensively washedwith lysis
buffer (150 mM NaCl). They were stored at 4C for mass spectrometry analyses.
Mass Spectrometry
Strep-Tactin beads containing the purified protein of interest and its interacting partners were washed twice with 100 mL of 25 mM
NH4HCO3 and an on-bead digestion with 0.2 mg of trypsin/LysC (Promega) was performed for 1 h in 100 mL of 25 mM NH4HCO3.
Samples were then loaded onto homemade C18 StageTips for desalting. Peptides were eluted using 40/60 MeCN/H2O + 0.1% for-
mic acid and vacuum concentrated to dryness. Samples were chromatographically separated using an RSLCnano system (Ultimate
3000, Thermo Scientific) coupled online to an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific). Peptides were trapped
on a C18 column (75 mm inner diameter 3 2 cm; nanoViper Acclaim PepMap<SUP>TM</SUP> 100, Thermo Scientific) with buffer
A (2/98 MeCN/H2O in 0.1% formic acid) at a flow rate of 4.0 mL/min over 4 min. Separation was performed on a 50 cm x 75 mmCell Reports 28, 1596–1611.e1–e10, August 6, 2019 e6
C18 column (nanoViper Acclaim PepMap<SUP>TM</SUP> RSLC, 2 mm, 100A˚, Thermo Scientific) regulated to a temperature of
45C with a linear gradient of 5% to 25% buffer B (100% MeCN in 0.1% formic acid) at a flow rate of 300 nL/min over 100 min.
Full-scan MS was acquired in the Orbitrap analyzer with a resolution set to 120,000 and ions from each full scan were HCD frag-
mented and analyzed in the linear ion trap.
For identification, the data were searched against the mouse SwissProt database using Sequest HF through proteome discoverer
version 2.1. Enzyme specificity was set to trypsin and a maximum of two-missed cleavage sites were allowed. Oxidized methionine,
N-terminal acetylation, and carbamidomethyl cysteine were set as variable modifications. Maximum allowedmass deviation was set
to 10 ppm for monoisotopic precursor ions and 0.6 Da for MS/MS peaks.
The resulting files were further processed usingmyProMS (Poullet et al., 2007). FDR calculation used Percolator andwas set to 1%
at the peptide level for the whole study. The label free quantification was performed by peptide Extracted Ion Chromatograms (XICs)
computed with MassChroQ version 1.2 (Valot et al., 2011).
For protein quantification, XICs from proteotypic and non-proteotypic peptides shared between compared conditions (TopN
matching) with no missed cleavages were used. Global MAD normalization was applied on the total signal to correct the XICs for
each biological replicate. Protein ratios were computed as the geometrical mean of related peptides. To estimate ratio significance,
a two-tailed t test was performed and p-values were adjusted with a Benjamini–Hochberg FDR procedure with a control threshold
set to 0.05.
A R 1.5 fold-change and R 3 peptides/protein were used as criteria to obtain a list of EML1 interacting partners (240). Further
filtering was performed (nucleic acid-associated proteins) refining the list of EML1 protein partners (113).
Additionally, to check for the specificity of the list of proteins obtained, we used the CRAPome (Contaminant Repository for Affinity
Purification, www.crapome.org), a depository that contains multiple negative controls frommass spectrometry experiments allowing
to query the specificity of the proteins obtained in MS results (Mellacheruvu et al., 2013). Only 3.3% of the proteins were recognized
as frequently found in the CRAPome data base, which ensures the specificity of the protein list.
Neuro2A Transfection, Co-immunoprecipitation
After 24 h in culture, cells reaching 70%–80% confluence were transfected using a ratio of 1:3 DNA and PEI, respectively (10 mg of
DNA and 30 mg of PEI, Polysciences). The following constructs were used for co-immunoprecipitation experiments: pMAX-Strep-
YFP-EML1, CMV-3xFlag-EML1, CMV-3xFlag-EML1 T243A, pEGFP-C3-EML1, pEGFP-C3-EML1 T243A, pCS2-c-myc-RPGRIP1L,
pCS2-c-myc-RPGRIP1L R1236C, pCS2-c-myc-RPGRIP1L V1188M, pCMV-3xFlag-VCIP135 (Delous et al., 2007; Kielar et al.,
2014; Zhang and Wang, 2015), and the corresponding control vectors. Site directed mutagenesis to obtain the c-myc-RPGRIP1L
mutant constructs was performed with the QuikChange Lightning Kit (Agilent Technologies). To test the shmiRNA efficiency, the
pCAGMIR30-shRNA scrambled and pCAGMIR30-shRNA Vcip135 constructs were transfected in Neuro2A cells.
For co-IPs, after 48 h, cells were recovered and washed twice with 1 X PBS and lysed by rotation for 20 min at 4C in 150 ml of RIPA
buffer (50 mM Tris-HCl, pH 8, 100 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Nonidet P-40, 0.5% sodium deoxycholate and protease
inhibitor mix from Roche). The samples were centrifuged at 14000 rcf. for 15 min at 4C. Protein G Sepharose beads (Sigma Aldrich)
were diluted 1/10 in TNE buffer (50 mM Tris-HCl pH 7.4, 100 mMNaCl, 5 mM EDTA) and 60 ml of diluted beads were used for each IP
experiment. The beadswere extensively washedwith 1 xRIPA buffer, followed by centrifugation (12000 rcf., 4C, 30 s). A pre-clearing
step was performed by incubating the cell lysates with the already-washed beads in a rotating wheel at 4C for 1 h 30 min. The
samples were then centrifuged (12000 rcf., 4C, 30 s) and the supernatant collected. The latter was incubated with the following
primary antibodies (1 mg): mouse anti-GFP (G6539, Sigma-Aldrich), rabbit anti-GFP (A6455, Invitrogen), rabbit anti-Flag (F7425,
Sigma-Aldrich), mouse anti-Flag (F1804, Sigma Aldrich), mouse anti-c-myc (Cell Signaling Technology) and mouse anti-Strep
(GT661, Invitrogen) (O/N, 4, rotating wheel).
Afterward, these samples were incubated with 100 ml of diluted washed Protein G Sepharose beads (5 h, 4C, rotating wheel). The
unbound fraction was recovered after centrifugation (12000 rcf., 4C, 30 s). 5x washes of the beads in 1 x RIPA buffer were performed
before elution with NuPAGE LDS Buffer (Thermo Fisher), 10 min at 70C. The bound fraction was recovered after centrifugation
(12000 rcf., RT, 2 min).
Western Blot
Samples were denatured with 2x NuPAGE LDS Buffer (ThermoFisher) for 10 min at 70C. Denaturing electrophoresis was performed
on a 4%–12% Bis-Tris Gel with MOPS SDS running buffer for 2 h at 110V. Proteins were transferred onto nitrocellulose membranes
for 2 h at 110V and 4C in a Tris-Glycine transfer buffer (Tris 25 mM, Glycine 192 mM, ethanol 10%). After protein transfer, the mem-
branes were stained with Ponceau S to check the transfer quality. This provided a loading control for the membranes revealing total
protein amounts in each lane. Themembranes were extensively washed with distilled water, followed by a 30min incubation in TBST
1x (100mM Tris pH 7.5, 150mMNaCl, 10% ethanol, 0.05% Tween) supplemented with 5%milk. Incubation with the secondary anti-
body (see below) was performed to identify non-specific binding sites. Briefly, the antibody was incubated in the dark for 2h, and
afterward extensive washes with TBST 1x were performed, prior to imaging (see below). The primary antibodies were then incubated
O/N at 4C with agitation or for a period of 2 h at RT. The following primary antibodies were used: goat anti-Gli3 (AF3690, R&D sys-
tems, 1:500), mouse anti-GFP (G6539, Sigma-Aldrich), rabbit anti-GFP (A6455, Invitrogen), rabbit anti-Flag (F7425, Sigma-Aldrich,
1:300), mouse anti-Flag (F1804, Sigma Aldrich, 1:500), mouse anti-c-myc (Cell Signaling Technology, 1:400), mouse anti-Strepe7 Cell Reports 28, 1596–1611.e1–e10, August 6, 2019
(GT661, Invitrogen, 1:1000), chicken anti-GAPDH (AB2302,Millipore, 1:10000). Themembraneswere extensively washedwith TBST,
followed by incubation with the secondary antibody: Dylight anti-mouse 800, anti-rabbit 800 and anti-chicken 680 (ThermoFisher,
1:10000). After extensive washes in TBST, the membranes were scanned using an Odyssey (Li-Cor) infrared scanner.
Mouse Progenitor Cell Culture Transfection
The cells were split once before performing transfection experiments. Half of the culture medium was changed by fresh complete
medium every 2 days. For splitting, cells were washed with pre-warmed Versene (GIBCO), followed by a 3 min incubation with
pre-warmed StemPro Accutase (GIBCO) at 37C. Cells were plated (6-8 3 10 5) on coated 14 mm glass coverslips for transfection.
For transfections (VSVts405-G-EGFP, pCMV-3xFlag-Eml1, pCAG-Galt-EGFP), a ratio of 1:2:2 DNA with Lipofectamine 3000 and
Lipofectamine 3000 Reagent was used. 1 ml of lipofectamine wasmixed with 25 ml of OPTI-MEM, and 0.5 mg of DNA were mixed with
2 ml of lipofectamine reagent in 50 ml of OPTI-MEM. The latter solution was mixed with the former and after 5 min at RT the mix was
applied to the cells.
For the VSVG experiments, cells were incubated at 39.5C and 5% CO2. 24 h later the cells were incubated at 32C to allow the
release of the VSVG protein. The cells were fixed 5 and 30 min afterward, and immunostained (see below).
Immunocytochemistry
Cells were washed in 1 x PBS prior to fixation with 4% w/v PFA in 0.1 M phosphate buffer, pH 7.4, for 15 min at RT. The cells were
extensively washed in 1 x PBS followed by a 15 min wash in PBST 0.2% (Triton X-100 0.2% in 1 x PBS). Incubation with blocking
solution (3% BSA, 0.2% Triton X-100 in 1 x PBS) was performed for 1 h at RT and the following primary antibodies were applied
for 2 h at RT or O/N at 4C: mouse anti-GFP (G6539, Sigma-Aldrich, 1:500), rabbit anti-Flag (F7425, Sigma-Aldrich, 1:500), mouse
anti-g-tubulin (GTU-88, T6557, Sigma-Aldrich, 1:500), rabbit anti-Arl13b (17711-1-AP, Proteintech, 1:500), sheep anti-TGN46
(AHP500GT, BioRad, 1:500), mouse anti-GM130 (610822, BD Biosciences, 1:300). The cells were extensively washed with PBST
0.2% and the following secondary antibodies were incubated combined with Hoechst (1:1000, ThermoFisher) for 45 min at RT in
the dark: anti-mouse Alexa 488, anti-mouse Alexa 568, anti-rabbit Alexa 568, anti-goat Alexa 568 (1:1000, ThermoFisher). The cells
were extensively washed in PBST 0.2% and the coverslips mounted with Fluoromount G (Southern Biotechnology). Images were
acquired with a TCS Leica SP5-II confocal microscope.
For detection of the neural and/or cortical progenitor markers SOX2, PAX6, FOXG1 and OTX2 and the primary cilium marker
ARL13B, cells were fixed for 10min in 4%w/v PFA (Sigma-Aldrich), washed three timeswith PBS and transferred to blocking solution
containing 10% FCS in PBS and 0.1% Triton X-100 for 1 h, incubated with the primary antibodies for 16 h at 4C, washed three times
with PBS, incubated for 1 h with secondary antibodies, counterstained with DAPI (BioLegend) and mounted with Mowiol 4-88.
Antibodies and concentrations were as follows: mouse anti-Sox2 (MAB2018, R&D Systems, 1:500), Pax6 (153011, Synaptic Sys-
tems, 1:300), Otx2 (M199, TaKaRa, 1:400), FoxG1 (M227, TaKaRa, 1:400), Arl13b (75-287, NeuroMab, 1:50), anti-rabbit Alexa 488
(1:1000, ThermoFisher) and anti-mouse Alexa 555 (1:1000, ThermoFisher). Images were acquired with a Celldiscoverer 7microscope
(Zeiss).
Shmir Design and RT-qPCR
pCAGMIR30-shRNA (Addgene) scrambled and pCAGMIR30-shRNA Vcip135 were designed with the siRNAWizard tool (Invivogen),
sequences are respectively: 50 TTGTGCCTCAGGACCTTATTA 30 and 50 TCCTAATTTCCGTGTGACAGT 30. Total RNA samples were
extracted from transfected Neuro2A cells (RNeasy protect mini kit, QIAGEN). First-strand cDNA was synthesized using oligo (dT)
and the Superscript III Reverse Transcriptase kit (Invitrogen). Gene-specific primers were designed by KiCqStart SYBR green
primers (Sigma Aldrich, primer set 1). The cyclophilin B (Ppib, peptidylpropyl isomerase B) and prosaposin (Psap) genes were
used for normalization (geometric mean). Real-time qPCRs were performed using the SYBR green method, following MIQE guide-
lines (Bustin et al., 2009). Standard curves were generated from assays made with serial dilutions of cDNA to calculate PCR effi-
ciencies (90% < efficiency < 105%, with r2 > = 0.998). Threshold cycles (Ct) were transformed into quantity values using the formula
(1 + efficiency)Ct. Differential expression analyses were performed with Student t tests.
In Utero Electroporation
Timed-pregnant mice (E13) were anesthetized with isoflurane (4% during induction and 2%–2.5% during surgery) and embryos
exposed within the intact uterine wall after sectioning the abdomen. Embryos were constantly hydrated with NaCl 0.9% (B. Braun).
A solution containing DNA (1 mg/ml per plasmid) and 20%w/v fast green in sterile endo-free water was injected in the lateral ventricles
of the embryos. Different combinations of plasmids were used of the following vectors: pCAGIG, pCAG-Arl13b-RFP (Jung et al.,
2016), pCS2-c-myc-RPGRIP1L R1236C, pCS2-c-myc-RPGRIP1L V118M, pCAG-IRES-Tomato, pEGFP-C3-EML1, pCAG-Galt-
EGFP (Kimura and Murakami, 2014), pCAGMIR30-shRNA scrambled and pCAGMIR30-shRNA Vcip135. Forceps electrodes
(SystemCUY650P5 NepaGene Co) were placed around the embryo head at a 45 angle and plasmids electroporated by discharging
a 4,000-mF capacitor charged to 35 V (five electric pulses of 50mswith 500ms intervals) with a CUY21NepaGene electroporator. The
embryos were then placed back in the abdominal cavity until a later developmental time point for subsequent analyses.Cell Reports 28, 1596–1611.e1–e10, August 6, 2019 e8
BrdU Injections and Immunohistochemistry
For cycling progenitor analyses at E12.5, pregnant females were injected with 5-bromo-20-deoxyuridine (BrdU, 99%Bioultra, Sigma-
Aldrich, 50 mg per gram body weight in NaCl 0.9%) and sacrificed after 30min. Embryonic brains were fixed by immersion O/N at 4C
in 4% w/v PFA in 0.1 M phosphate buffer, pH 7.4, followed by extensive washes in 1 x PBS. Brains were cut in 70 mm thick
coronal sections using a vibrating blade microtome (Leica VT1000 S). In order to perform immunohistochemistry combining the
primary antibodies mouse anti-Ki67 (BD 556003, 1:200) and rat anti-BrdU (BioRad, MCA2060GA, 1:1000), antigen retrieval was
performed by incubating the sections in sodium citrate 10 mM pH 6 at 95C for 20 min and allowing them to cool before blocking.
Blocking was performed for 1 h at RT with blocking solution (1X PBSwith 10%Goat Serum and 0.5% Triton X-100) before incubation
O/N at 4C with the primary antibody (Ki67, proliferation marker). After extensive washes, sections were incubated with the
secondary antibody anti-rabbit Alexa 488 (Life Technologies, 1:1000) for 2 h at RT. This was followed by a 10 min incubation in
Hoechst (ThermoFisher, 1:1000) and then sections were fixed with 8% PFA w/v for 15 min at RT (Palmer et al., 2000). Extensive
washes with PBST 0.1% (1X PBS and 0.1% Triton X-100) were performed, followed by incubation in 2N hydrochloric acid for
30 min at 37C. After extensive washes, the sections were incubated with the primary antibody (BrdU), secondary antibody Alexa
568 (Life Technologies, 1:1000), Hoechst, and then mounted with Fluoromount G (Invitrogen).
Brain sections (50 mm thick) from in utero electroporation experiments related to Vcip135 were exclusively incubated with Hoechst
and extensively washed before mounting. For other IHC experiments (brain sections 50-70 mm thick) the following primary antibodies
were used: mouse anti-GFP (G6539, Sigma-Aldrich, 1:500), chicken anti-GFP (AB16901, Millipore, 1:500), rabbit anti-Pax6 (901301,
BioLegend, 1:300), anti-Arl13b (17711-1-AP, Proteintech, 1:500) and secondary antibodies Alexa 488, Alexa-568 and Alexa-647
(ThermoFisher).
QUANTIFICATION AND STATISTICAL ANALYSIS
En Face Imaging
Images were acquired with a 0.17 mm z stack depth. At least two randomly-chosen ROIs (1003 100 mm) were analyzed per embryo,
and the analyzed images had a total depth of 1 mm. Images were analyzed using the ImageJ plugin Tissue Analyzer (Aigouy et al.,
2010) and the publicly available software Cell Profiler (Lamprecht et al., 2007), a method previously described in Foerster et al., 2017.
Electron Microscopy
Images were analyzed using ImageJ.
Immunohistochemistry and Immunocytochemistry Images
Images were analyzed using ImageJ. For Ki67+BrdU+ cell distribution analyses, regions of interest (ROI) were selected from both
hemispheres, spanning the whole cortical wall and with a width of 100 mm. Two ROIs were quantified per animal. The E12.5 cortical
wall was divided in five equally-sized bins, bin 1 and 5 corresponding to the most apical (apical ventricular zone) and basal (cortical
plate) regions of the developing cortex, respectively (Figure S1A). For in utero electroporation experiments and primary cilia (Arl13b+)
distribution analyses (Figures S2D, S5A, and S1L, respectively), the E13.5 or E14 cortex was subdivided in 6-equally sized bins, bin 1
and 6 corresponding to the most apical (apical ventricular zone) and basal (cortical plate) regions of the developing cortex, respec-
tively. Cells that were positive in each bin for the selected markers were quantified, and the percentage relative to the total number of
positive cells across the cortical wall was compared between the two conditions in each different bin. For primary cilium analyses, the
number of Arl13b+ cilia in each bin was quantified, normalized by the total number across the different bins.
For in utero electroporation experiments addressing Golgi apparatus localization in aRGs, individual electroporated Tomato+ cells
were selected and analyzed. Similar parameters to the ones described in Taverna et al., 2016 were quantified.
For patient fibroblast primary cilium and Golgi apparatus analyses ImageJ was used. Axoneme length was measured manually
using Arl13b immunodetections. Golgi analyses were performed with the plugin 3D Object Counter.
Images for all experiments were acquired with a TCS Leica SP5-II confocal microscope. A stack projection 10 mm thick was used
for the IHC analyses. A stack projection 3-5 mm thick was used for ICC analyses. Stacks were performed using ImageJ.
Immunoprecipitation and Western Blot
Images were analyzed using ImageJ. For co-immunoprecipitation experiments, the bound fraction was normalized to the total
(bound and unbound). ‘Bound’ refers to the fraction of the prey recombinant protein interacting with the bait recombinant protein.
‘UB’ refers to unbound protein which does not get pulled down. This indicates the fraction of prey recombinant protein still found
in the lysate after incubation with the bait protein. Even if an interaction between recombinant proteins is found, the bait and prey
recombinants protein can still also be found in the unbound fraction, since they are produced in excess. For each experiment shown
the bait is specified in the figure (e.g., ‘IP: anti-Flag’ above the blot refers to the fact that the bait is the Flag-tagged protein). The de-
tected prey is shown in the upper panel of blots. The graphs measure the band intensity in the western blots. The bound band of the
prey protein is normalized to the total amount of protein. This is then normalized to the levels of bait protein. When comparing thee9 Cell Reports 28, 1596–1611.e1–e10, August 6, 2019
interaction betweenWT andmutant forms of recombinant proteins, we considered the interaction betweenWT recombinant proteins
as the baseline (this was hence set to 1). Therefore, the quantifications concerning mutant constructs are normalized to the values
obtained for the interaction of the WT recombinant proteins.
For Gli TFs analyses, band intensity was measured and normalized to GAPDH.
Statistical Analyses
Statistical analyses were performed using GraphPad Prism and BiostaTGV (https://biostatgv.sentiweb.fr/). The specific test used in
each experiment is specified in the figure legend. Data were collected and processed randomly. No data points were excluded.
DATA AND CODE AVAILABILITY
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol
et al., 2019) partner repository with the dataset identifier PXD012714. The accession number for the mass spectrometry proteomics
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